Read the latest expert‐written articles on recently published manuscripts that make influential contributions to the body of infectious diseases literature.
The possibility of a new antiviral class administered as a single oral dose that is well tolerated will be a welcome addition to the treatment armamentarium for #influenza. However, its use should be limited to carefully selected individuals.
Fecal microbiota transplantation (FMT) is a widely accepted, safe, and effective treatment for recurrent Clostridium difficile infection (rCDI), but does the cure endure?
Alternative agents are often broader spectrum than ß-lactams, subjecting patients to collateral damage and subsequent selection for resistant organisms and Clostridium difficile.
